Biocare Medical launches seven IVD antibodies

Create PDF

“We are proud to be able to launch novel, IVD IHC markers that meet the highest standards in cancer diagnostics. This commitment to quality ensures Biocare is providing the best diagnostic and research utility possible,” Jason Ramos, PhD, vice president of reagent research and development at Biocare Medical, said in a press release.